Literature DB >> 33400703

Appropriateness and affordability of prescriptions to diabetic patients attending a tertiary hospital in Eastern Uganda: A retrospective cross-sectional study.

Samuel Baker Obakiro1, Kenedy Kiyimba1, Agnes Napyo2, Andrew Marvin Kanyike2, Wilberforce John Mayoka3, Aishah Ggalabuzi Nnassozi1, Beatrice Aguti2, Gabriel Madut Akech2, John Paul Waako1.   

Abstract

BACKGROUND: Irrational prescription of drugs can lead to high cost of treatment thus limiting access to essential medicines. We assessed the affordability and appropriateness of prescriptions written for diabetic patients in Eastern Uganda.
METHODS: We collected secondary data from the health management information system registers of patients who attended the outpatient medical clinic at Mbale regional referral hospital from January 2019 to December 2019. The average cost of the prescriptions was calculated and adjusted odds ratios for predictors for unaffordability estimated using logistic regression. Computed scores for indicators of rational drug prescription were used to assess the extent of rational prescribing.
RESULTS: The median cost per prescription was USD 11.34 (IQR 8.1, 20.2). Majority of the diabetic patients (n = 2462; 94.3%, 95% CI: 93.3-95.1%) could not afford the prescribed drugs. Predictors for unaffordability were if a prescription contained: ≥ 4 medicines (AOR = 12.45; 95% CI: 3.9-39.7); an injectable (AOR = 5.47; 95%CI: 1.47-20.32) and a diagnosis of diabetes mellitus with other comorbidities (AOR = 3.36; 95%CI: 1.95-5.78). Having no antidiabetic drug prescribed was protective for non-affordability (AOR = 0.38; 95%CI: 0.24-0.61). The average number of drugs per prescription was 2.8. The percentage prescription of drugs by generic name and from the essential medicine and health supplies list of Uganda were (6160/7461; 82.6%, 96% CI: 81.7%-83.4%) and (6092/7461; 81.7%, 95% CI: 80.8%-82.5%) respectively against WHO standard of 100%.
CONCLUSION: The majority of diabetic patients (94.3%) in Eastern Uganda cannot afford to buy prescribed medicines. The government should therefore ensure that essential medicines are readily accessible in public health facilities.

Entities:  

Year:  2021        PMID: 33400703      PMCID: PMC7785215          DOI: 10.1371/journal.pone.0245036

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  14 in total

1.  The availability, price and affordability of antidiabetic drugs in Hubei province, China.

Authors:  Shiwei Gong; Hongbing Cai; Yufeng Ding; Weijie Li; Xu Juan; Jinlan Peng; Si Jin
Journal:  Health Policy Plan       Date:  2018-10-01       Impact factor: 3.344

2.  Global estimates of diabetes prevalence for 2013 and projections for 2035.

Authors:  L Guariguata; D R Whiting; I Hambleton; J Beagley; U Linnenkamp; J E Shaw
Journal:  Diabetes Res Clin Pract       Date:  2013-12-01       Impact factor: 5.602

3.  Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries.

Authors:  Catherine E Vialle-Valentin; Brian Serumaga; Anita K Wagner; Dennis Ross-Degnan
Journal:  Health Policy Plan       Date:  2014-09-24       Impact factor: 3.344

4.  Prevalence and correlates of diabetes mellitus in Uganda: a population-based national survey.

Authors:  Silver Bahendeka; Ronald Wesonga; Gerald Mutungi; James Muwonge; Stella Neema; David Guwatudde
Journal:  Trop Med Int Health       Date:  2016-01-21       Impact factor: 2.622

5.  Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study.

Authors:  Clara K Chow; Chinthanie Ramasundarahettige; Weihong Hu; Khalid F AlHabib; Alvaro Avezum; Xiaoru Cheng; Jephat Chifamba; Gilles Dagenais; Antonio Dans; Bonaventure A Egbujie; Rajeev Gupta; Romaina Iqbal; Noorhassim Ismail; Mirac V Keskinler; Rasha Khatib; Lanthé Kruger; Rajesh Kumar; Fernando Lanas; Scott Lear; Patricio Lopez-Jaramillo; Martin McKee; Noushin Mohammadifard; Viswanathan Mohan; Prem Mony; Andres Orlandini; Annika Rosengren; Krishnapillai Vijayakumar; Li Wei; Karen Yeates; Khalid Yusoff; Rita Yusuf; Afzalhussein Yusufali; Katarzyna Zatonska; Yihong Zhou; Shariful Islam; Daniel Corsi; Sumathy Rangarajan; Koon Teo; Hertzel C Gerstein; Salim Yusuf
Journal:  Lancet Diabetes Endocrinol       Date:  2018-08-28       Impact factor: 32.069

Review 6.  Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management.

Authors:  Arun Chaudhury; Chitharanjan Duvoor; Vijaya Sena Reddy Dendi; Shashank Kraleti; Aditya Chada; Rahul Ravilla; Asween Marco; Nawal Singh Shekhawat; Maria Theresa Montales; Kevin Kuriakose; Appalanaidu Sasapu; Alexandria Beebe; Naveen Patil; Chaitanya K Musham; Govinda Prasad Lohani; Wasique Mirza
Journal:  Front Endocrinol (Lausanne)       Date:  2017-01-24       Impact factor: 5.555

7.  Comparison of Oral Antidiabetic Drugs as Add-On Treatments in Patients with Type 2 Diabetes Uncontrolled on Metformin: A Network Meta-Analysis.

Authors:  Dan Qian; Tiantian Zhang; Peiying Zheng; Zhuoru Liang; Sen Wang; Jingmei Xie; Lina Zhao; Ying Zhang; Bing Situ
Journal:  Diabetes Ther       Date:  2018-08-18       Impact factor: 2.945

8.  Comparison of medication adherence between type 2 diabetes mellitus patients who pay for their medications and those who receive it free: a rural Asian experience.

Authors:  Devarajan Rathish; Ruvini Hemachandra; Thilini Premadasa; Sasini Ramanayake; Chathuri Rasangika; Ravi Roshiban; Channa Jayasumana
Journal:  J Health Popul Nutr       Date:  2019-01-24       Impact factor: 2.000

9.  Assessment of drug use pattern using WHO prescribing indicators at Hawassa University Teaching and Referral Hospital, south Ethiopia: a cross-sectional study.

Authors:  Anteneh Assefa Desalegn
Journal:  BMC Health Serv Res       Date:  2013-05-07       Impact factor: 2.655

10.  Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia.

Authors:  Andrea Hannah Kaiser; Lindsey Hehman; Birger Carl Forsberg; Warren Mukelabai Simangolwa; Jesper Sundewall
Journal:  PLoS One       Date:  2019-12-13       Impact factor: 3.240

View more
  2 in total

1.  Prevalence and factors associated with inappropriate anti- diabetic medication therapy among type 2 diabetes mellitus patients at the medical and surgical wards of Mbarara Regional Referral Hospital, Uganda.

Authors:  Konjit Abebe Nigussie; Efrata Ashuro Shegena; Obwoya Paul Stephen; Juliet Sanyu Namugambe; Tadele Mekuriya Yadesa
Journal:  PLoS One       Date:  2022-06-29       Impact factor: 3.752

2.  The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future.

Authors:  Brian Godman; Mainul Haque; Trudy Leong; Eleonora Allocati; Santosh Kumar; Salequl Islam; Jaykaran Charan; Farhana Akter; Amanj Kurdi; Carlos Vassalo; Muhammed Abu Bakar; Sagir Abdur Rahim; Nusrat Sultana; Farzana Deeba; M A Halim Khan; A B M Muksudul Alam; Iffat Jahan; Zubair Mahmood Kamal; Humaira Hasin; Shamsun Nahar; Monami Haque; Siddhartha Dutta; Jha Pallavi Abhayanand; Rimple Jeet Kaur; Godfrey Mutashambara Rwegerera; Renata Cristina Rezende Macedo do Nascimento; Isabella Piassi Dias Godói; Mohammed Irfan; Adefolarin A Amu; Patrick Matowa; Joseph Acolatse; Robert Incoom; Israel Abebrese Sefah; Jitendra Acharya; Sylvia Opanga; Lisper Wangeci Njeri; David Kimonge; Hye-Young Kwon; SeungJin Bae; Karen Koh Pek Khuan; Abdullahi Rabiu Abubakar; Ibrahim Haruna Sani; Tanveer Ahmed Khan; Shahzad Hussain; Zikria Saleem; Oliver Ombeva Malande; Thereza Piloya-Were; Rosana Gambogi; Carla Hernandez Ortiz; Luke Alutuli; Aubrey Chichonyi Kalungia; Iris Hoxha; Vanda Marković-Peković; Biljana Tubic; Guenka Petrova; Konstantin Tachkov; Ott Laius; András Harsanyi; András Inotai; Arianit Jakupi; Svens Henkuzens; Kristina Garuoliene; Jolanta Gulbinovič; Magdalene Wladysiuk; Jakub Rutkowski; Ileana Mardare; Jurij Fürst; Stuart McTaggart; Sean MacBride-Stewart; Caridad Pontes; Corinne Zara; Eunice Twumwaa Tagoe; Rita Banzi; Janney Wale; Mihajlo Jakovljevic
Journal:  Front Public Health       Date:  2021-06-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.